Can Head & Shoulders cause hair loss? It is one of the most commonly searched questions about this popular anti-dandruff shampoo, and understandably so. Head & Shoulders has undergone formulation changes in the UK following regulatory updates affecting zinc pyrithione, its historically primary active ingredient. This article examines what the product contains, what the clinical evidence says about anti-dandruff shampoos and hair shedding, the many well-established causes of hair loss worth considering, and when it is appropriate to seek advice from a GP or dermatologist.

What Head & Shoulders Contains and How It Works

Head & Shoulders is a cosmetic anti-dandruff shampoo; many current UK formulations have replaced zinc pyrithione with piroctone olamine following regulatory changes, so checking the INCI list on your specific pack is essential.

Head & Shoulders is one of the most widely used anti-dandruff shampoos in the UK. Historically, its primary active ingredient was zinc pyrithione (ZPT), typically at 1% concentration. However, following regulatory changes in the EU — and with Great Britain moving to align — many current UK formulations no longer contain zinc pyrithione. Some variants now use alternatives such as piroctone olamine. Formulations vary by product line, so it is important to check the ingredient list (INCI list) on the UK pack you are using, as this will confirm the active ingredient in your specific product.

Zinc pyrithione, where present, works by exerting antifungal and antibacterial properties against Malassezia globosa, a naturally occurring yeast on the scalp strongly associated with dandruff and seborrhoeic dermatitis. By reducing the overgrowth of this yeast, it helps to control the flaking, itching, and inflammation that characterise these conditions.

It is important to understand the regulatory distinction between cosmetic and medicinal shampoos in the UK. Head & Shoulders is classified as a cosmetic product, regulated under the UK Cosmetics Regulation by the Office for Product Safety and Standards (OPSS) — not the MHRA. By contrast, some anti-dandruff shampoos — such as those containing ketoconazole 2%, selenium sulfide 2.5%, or coal tar — are MHRA-licensed medicines and carry a different regulatory and safety-reporting framework. Suspected side effects from licensed medicinal shampoos should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

For most users, Head & Shoulders is well tolerated. Reported side effects are generally mild and may include scalp dryness or minor irritation, particularly with frequent use. Understanding what the product contains helps contextualise concerns about whether it could contribute to hair loss — a question that many users raise online and with their pharmacists.

Is Hair Loss a Known Side Effect of Anti-Dandruff Shampoos?

There is no convincing evidence that cosmetic anti-dandruff shampoos cause hair loss when used as directed; increased shedding reported by some users is more likely attributable to coincidental timing or an underlying condition.

Concerns about anti-dandruff shampoos causing hair loss are frequently raised on patient forums and social media, but it is important to approach this question with clinical nuance. There is no convincing evidence that typical cosmetic anti-dandruff shampoos — including those previously containing zinc pyrithione — cause hair loss when used as directed. Because these products are cosmetics rather than medicines, they are not subject to MHRA or EMA adverse effect reporting in the same way as licensed medicines.

For MHRA-licensed medicated shampoos, the picture is slightly more nuanced. The Summary of Product Characteristics (SmPC) for ketoconazole 2% shampoo, for example, lists hair loss or altered hair texture as uncommon or rare adverse effects. This does not mean such effects are common or expected, but it is worth being aware of when choosing a product.

Some individuals do report noticing increased hair shedding after starting an anti-dandruff shampoo. In many cases, this may be attributable to coincidental timing rather than a causal relationship. Hair loss has many underlying causes — hormonal, nutritional, genetic, and stress-related — and it is common for people to associate a new product with a symptom that was already developing.

It is also worth noting that dandruff and seborrhoeic dermatitis themselves can contribute to a degree of hair shedding. Chronic scalp inflammation, if left untreated, may disrupt the hair follicle environment and lead to temporary hair thinning. In this context, treating the underlying scalp condition appropriately could be beneficial rather than harmful.

If allergic contact dermatitis occurs in response to any shampoo ingredient — including fragrances or preservatives — this could theoretically affect the local follicular environment. Such reactions are uncommon but would typically present with redness, itching, or a rash before any hair loss became apparent. Discontinuing the product and seeking advice from a pharmacist or GP would be the appropriate response. In children or adults with inflammatory, scaly patches and patchy hair loss, tinea capitis (scalp ringworm) should be considered and assessed promptly by a GP.

What the Evidence Says About Zinc Pyrithione and Hair Loss

The available evidence does not support the conclusion that zinc pyrithione at cosmetic concentrations causes hair loss; some limited studies suggest a neutral or modestly beneficial effect on hair shedding via scalp inflammation control.

The scientific literature on zinc pyrithione and hair loss is limited but broadly reassuring. Some studies have investigated zinc pyrithione in the context of hair retention and scalp health, with findings suggesting a potentially neutral or modestly beneficial role. Research published in the British Journal of Dermatology has reported that regular use of a 1% zinc pyrithione shampoo was associated with a modest reduction in hair shedding compared to a placebo shampoo, likely attributable to its effect on scalp inflammation and Malassezia control. However, these studies are limited in size and some have received industry funding; readers should interpret findings with appropriate caution.

There is no robust clinical evidence from large randomised controlled trials or observational studies demonstrating that zinc pyrithione at cosmetic concentrations causes or accelerates hair loss in humans. The ingredient has been in widespread use for decades, and its tolerability at 1% concentration is considered acceptable by dermatological standards — though the absence of proven harm should not be equated with a guarantee of safety for all individuals.

It is important to note that zinc pyrithione's regulatory status in cosmetics has changed. The European Commission restricted ZPT in rinse-off cosmetic products (Regulation EU 2021/1902), citing environmental and safety concerns. Great Britain is in the process of considering alignment with these changes. As a result, many current UK Head & Shoulders formulations no longer contain ZPT. Restrictions on ZPT in industrial biocidal applications are a separate matter but share the same underlying regulatory review process.

In summary, the current weight of evidence does not support the conclusion that anti-dandruff shampoos containing zinc pyrithione cause hair loss when used as directed. Individuals who notice hair shedding while using such products are encouraged to consider other, more clinically established causes.

Common Causes of Hair Loss Worth Ruling Out

Androgenetic alopecia, telogen effluvium, ferritin deficiency, and thyroid dysfunction are among the most clinically established causes of hair loss and should be investigated before attributing shedding to a shampoo.

Hair loss is a common concern in the UK, affecting both men and women across all age groups. Before attributing shedding to a shampoo, it is clinically important to consider the many well-established causes:

• Androgenetic alopecia (male or female pattern hair loss): The most common cause of progressive hair thinning, driven by genetic sensitivity to dihydrotestosterone (DHT). It typically follows a predictable pattern and is unrelated to shampoo use.

• Telogen effluvium: A temporary, diffuse shedding of hair that often follows physical or emotional stress, illness, surgery, rapid weight loss, or childbirth. It can begin two to three months after the triggering event, making it easy to mistakenly associate with a recently changed product.

• Nutritional deficiencies: Low levels of ferritin (iron stores) are associated with hair shedding and can be identified with a blood test. Testing for vitamin D, zinc, or biotin is not routinely recommended in UK primary care unless there is a specific clinical indication; biotin supplements in particular can interfere with certain laboratory assays.

• Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can cause diffuse hair loss. NICE CKS guidance supports thyroid function testing (TSH) in patients presenting with unexplained diffuse hair loss.

• Tinea capitis (scalp ringworm): A fungal infection causing patchy hair loss with scaling, particularly common in children. It requires prompt GP assessment and antifungal treatment — it will not resolve with anti-dandruff shampoo alone.

• Alopecia areata: An autoimmune condition causing patchy hair loss, managed by dermatologists and sometimes treated with topical corticosteroids or other immunotherapies.

• Scarring alopecias: A group of conditions (such as lichen planopilaris or frontal fibrosing alopecia) in which inflammation permanently destroys hair follicles. Early specialist assessment is important to limit progression.

• Medications: Certain drugs — including anticoagulants, retinoids, antidepressants, and some blood pressure medications — list alopecia as a recognised side effect.

Understanding these causes is essential because treating the correct underlying condition is far more effective than changing shampoo brands. A GP can help identify the cause through a structured history, examination, and targeted blood tests, guided by NICE CKS recommendations.

When to Speak to a GP or Dermatologist About Hair Loss

See a GP if you notice sudden, patchy, or progressive hair loss, especially if accompanied by scalp changes, systemic symptoms, or hair loss in a child, as prompt assessment guides correct diagnosis and treatment.

Most people experience some degree of hair shedding — losing up to 100 hairs per day is considered within the normal range. However, there are specific circumstances in which it is important to seek professional advice rather than self-managing with over-the-counter products.

You should contact your GP if you notice:

• Sudden or rapid hair loss over a short period

• Patchy bald areas on the scalp, beard, or eyebrows

• Hair loss accompanied by scalp pain, redness, scaling, or scarring

• Diffuse thinning that is progressively worsening

• Hair loss alongside other symptoms such as fatigue, weight changes, or irregular periods

• Hair loss in a child or teenager — tinea capitis should be excluded promptly

• Any signs of a spreading, inflamed, or crusted scalp patch (which may indicate a kerion or scarring process requiring urgent assessment)

Your GP will typically take a detailed history, examine the scalp, and may arrange blood tests. In line with NICE CKS guidance, investigations for diffuse hair loss commonly include a full blood count (FBC), ferritin, and thyroid function (TSH). Further tests are arranged based on clinical findings rather than as a routine panel.

If the cause remains unclear, the hair loss is significant, or a scarring alopecia is suspected, your GP may refer you to a consultant dermatologist with a specialist interest in hair disorders. NHS dermatology services can offer more advanced investigations, including scalp biopsy if scarring alopecia is suspected, or dermoscopy to assess follicular health. Note that while the term 'trichologist' is sometimes used, trichologists are not medical doctors; formal medical assessment and treatment require referral to a consultant dermatologist.

If you are using a licensed medicinal shampoo (such as ketoconazole 2% or selenium sulfide 2.5%) and suspect it may be contributing to hair loss or another side effect, you can report this via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Stopping a shampoo you suspect is causing problems is a reasonable first step, but this alone is unlikely to resolve hair loss if an underlying medical or hormonal cause is present. Seeking timely professional advice ensures the correct diagnosis and avoids unnecessary delays in treatment.

Choosing a Shampoo Safely: NHS and Dermatologist Guidance

The NHS recommends medicated anti-dandruff shampoos such as ketoconazole 2% or selenium sulfide 2.5% as first-line treatments for dandruff; patch testing new products and following label instructions reduces the risk of scalp irritation.

For individuals with dandruff or seborrhoeic dermatitis, the NHS recommends using a medicated anti-dandruff shampoo as a first-line treatment. Several active ingredients are available in the UK, with different regulatory classifications:

• Ketoconazole 2% shampoo (e.g., Nizoral): A Pharmacy (P) medicine available without a prescription from a pharmacist. It is an antifungal with good evidence for seborrhoeic dermatitis.

• Selenium sulfide 2.5% shampoo (e.g., Selsun): Also a Pharmacy (P) medicine available without a prescription. Effective for dandruff and seborrhoeic dermatitis.

• Coal tar shampoos (e.g., T/Gel): MHRA-licensed medicines with anti-inflammatory and antifungal properties, suitable for dandruff and scalp psoriasis.

• Piroctone olamine and other cosmetic actives: Found in some cosmetic anti-dandruff shampoos, including some current Head & Shoulders formulations, following changes to zinc pyrithione's regulatory status.

When selecting a shampoo, the following general advice applies:

• Check the label and follow the usage instructions. Most anti-dandruff shampoos are intended for regular but not necessarily daily use.

• Patch test new products if you have sensitive skin or a history of contact dermatitis. Apply a small amount to the inner forearm and wait 24–48 hours before use on the scalp.

• Avoid leaving shampoo on the scalp for longer than recommended, as this may increase the risk of irritation.

• If one active ingredient does not improve your symptoms after two to four weeks of regular use, the NHS and British Association of Dermatologists (BAD) suggest trying a product with a different active ingredient.

• If you experience scalp irritation, redness, or increased shedding after starting a new shampoo, discontinue use and consult a pharmacist or GP.

For those concerned about hair loss specifically, it is worth discussing shampoo choices with a healthcare professional rather than relying solely on online reviews. A pharmacist can provide guidance on suitable products without a prescription, while a GP or dermatologist can offer a more comprehensive assessment if hair loss is a significant concern.

In summary, there is no convincing evidence that typical use of anti-dandruff shampoos — including Head & Shoulders — causes hair loss when used as directed. Maintaining a healthy scalp environment through appropriate cleansing and treatment of conditions such as dandruff is, in fact, supportive of overall hair health.

Frequently Asked Questions